Among the seven patients who tested strongly positive for the anti-SAE1 autoantibody and met the criteria for IIM, three were diagnosed with DM, two with CADM, one with PM, and one with OM in the context of concurrent myositis and SSc. This evidence concerns the gene SAE1 and clinically amyopathic dermatomyositis.